At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Blood Saving Effect and Wound-related Complications of Tranexamic Acid in Mininally Invasive Total Knee Arthroplasty With Rivaroxaban as Thromboprophylaxis
In Brief
A Phase 4 clinical trial evaluating Tranexamic Acid 5%,5ml/amp (intraoperative), Tranexamic Acid 5%,5ml/amp (3 hours after operation), and 3 other interventions for Osteoarthritis, Knee. Completed, enrolled 294 participants across 1 site.
Detailed Summary
The aim of this study was to conduct a prospective, randomized, double-blind study and assess the efficacy of and safety for thromboprophylaxis of rivaroxaban in total knee arthroplasty patients when tranexamic acid is used for bleeding prophylaxis.
Study Details
Timeline
Interventions
tranexamic acid 1g administered intravenously five minutes before deflation of the tourniquet
tranexamic acid 1g administered intravenously 3 hours after operation
0.9% Normal Saline 20ml administered intravenously five minutes before deflation of the tourniquet
0.9% Normal Saline 20ml administered intravenously 3 hours after operation
Oral rivaroxabam (10mg) QD on PostOp Day 1 to 14